Candriam S.C.A. Decreases Position in Synopsys, Inc. $SNPS

Candriam S.C.A. trimmed its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 19.1% in the first quarter, Holdings Channel.com reports. The institutional investor owned 73,311 shares of the semiconductor company’s stock after selling 17,301 shares during the quarter. Candriam S.C.A.’s holdings in Synopsys were worth $29,066,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in SNPS. Sowell Financial Services LLC lifted its position in Synopsys by 2.0% during the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after buying an additional 21 shares in the last quarter. Natural Investments LLC increased its stake in shares of Synopsys by 4.6% in the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after acquiring an additional 21 shares during the last quarter. Financial Management Professionals Inc. raised its holdings in shares of Synopsys by 7.0% during the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after acquiring an additional 22 shares during the period. Foronjy Financial LLC grew its holdings in shares of Synopsys by 5.2% in the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after purchasing an additional 22 shares during the period. Finally, Barden Capital Management Inc. increased its position in Synopsys by 1.2% during the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock worth $877,000 after purchasing an additional 23 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Up 0.5%

Synopsys stock traded up $2.13 during mid-day trading on Friday, reaching $445.50. 839,512 shares of the company’s stock were exchanged, compared to its average volume of 1,858,163. The company has a fifty day moving average of $477.80 and a 200-day moving average of $460.71. The company has a market cap of $85.30 billion, a P/E ratio of 103.12, a P/E/G ratio of 2.62 and a beta of 1.22. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the business posted $3.67 earnings per share. Synopsys’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on SNPS shares. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Bank of America upped their target price on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Citigroup increased their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, BNP Paribas Exane boosted their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $570.06.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.